辅助化疗在早期可手术非小细胞肺癌治疗中的地位

Postoperative recurrence is the main cause of primary treatment failure in the resectable non-small cell lung cancer (NSCLC). Systematic treatments should be taken to decrease the recurrence. Adjuvant chemotherapy, including neoadjuvant chemotherapy, postoperative adjuvant chemotherapy and targeted...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2011
Materias:
综述
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999668/
https://www.ncbi.nlm.nih.gov/pubmed/21426675
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.03.15
_version_ 1783331472455761920
collection PubMed
description Postoperative recurrence is the main cause of primary treatment failure in the resectable non-small cell lung cancer (NSCLC). Systematic treatments should be taken to decrease the recurrence. Adjuvant chemotherapy, including neoadjuvant chemotherapy, postoperative adjuvant chemotherapy and targeted therapy, is a widely used in this area. In this review, we summarize the clinical trials and meta-analysis related to the adjuvant chemotherapy and targeted therapy in patients with early stage NSCLC.
format Online
Article
Text
id pubmed-5999668
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59996682018-07-06 辅助化疗在早期可手术非小细胞肺癌治疗中的地位 Zhongguo Fei Ai Za Zhi 综述 Postoperative recurrence is the main cause of primary treatment failure in the resectable non-small cell lung cancer (NSCLC). Systematic treatments should be taken to decrease the recurrence. Adjuvant chemotherapy, including neoadjuvant chemotherapy, postoperative adjuvant chemotherapy and targeted therapy, is a widely used in this area. In this review, we summarize the clinical trials and meta-analysis related to the adjuvant chemotherapy and targeted therapy in patients with early stage NSCLC. 中国肺癌杂志编辑部 2011-03-20 /pmc/articles/PMC5999668/ /pubmed/21426675 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.03.15 Text en 版权所有©《中国肺癌杂志》编辑部2011 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 综述
辅助化疗在早期可手术非小细胞肺癌治疗中的地位
title 辅助化疗在早期可手术非小细胞肺癌治疗中的地位
title_full 辅助化疗在早期可手术非小细胞肺癌治疗中的地位
title_fullStr 辅助化疗在早期可手术非小细胞肺癌治疗中的地位
title_full_unstemmed 辅助化疗在早期可手术非小细胞肺癌治疗中的地位
title_short 辅助化疗在早期可手术非小细胞肺癌治疗中的地位
title_sort 辅助化疗在早期可手术非小细胞肺癌治疗中的地位
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999668/
https://www.ncbi.nlm.nih.gov/pubmed/21426675
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.03.15
work_keys_str_mv AT fǔzhùhuàliáozàizǎoqīkěshǒushùfēixiǎoxìbāofèiáizhìliáozhōngdedewèi
AT fǔzhùhuàliáozàizǎoqīkěshǒushùfēixiǎoxìbāofèiáizhìliáozhōngdedewèi
AT fǔzhùhuàliáozàizǎoqīkěshǒushùfēixiǎoxìbāofèiáizhìliáozhōngdedewèi
AT fǔzhùhuàliáozàizǎoqīkěshǒushùfēixiǎoxìbāofèiáizhìliáozhōngdedewèi
AT fǔzhùhuàliáozàizǎoqīkěshǒushùfēixiǎoxìbāofèiáizhìliáozhōngdedewèi
AT fǔzhùhuàliáozàizǎoqīkěshǒushùfēixiǎoxìbāofèiáizhìliáozhōngdedewèi

Ejemplares similares